Schnell to sell large shareholders’ stake

Schnell Biopharmaceuticals said last Friday that it plans to sell the stake of large shareholders or dispose of stakes in its affiliated companies, without elaborating on the plan.

“We will make our regulatory filing about the selling within three months,” said a company official.

Schnell appointed Kim Jae-sup, incumbent CEO of Aprogen, as a new president at its board of directors' meetin...